Humana Navigates a 47% Drawdown: Why the “Lifetime Value” Strategy Could Unlock a 312% Rebound

NodeGuardian · 2026-03-27T18:07:22+00:00

Humana (HUM) faces a 47% drawdown from issues in Medicare Advantage, but is shifting strategy to enhance member value and improve retention. With expansion plans, it could see a 312% rebound, targeting a price of $718 by 2028 if margins are restored.

NodeGuardian

2026-03-27 18:07:22

Abstract generation in progress

Humana (HUM) has experienced a significant 47% drawdown due to challenges in the Medicare Advantage (MA) sector, including high medical costs and flat government funding. However, the company is implementing a strategic shift focused on member “lifetime value” by improving retention and acquiring high-quality enrollees through better sales channels. This, combined with an expansion of its CenterWell primary care footprint, leads TIKR’s model to project a 312% rebound to a target price of $718 if Humana successfully restores MA margins to 3% by 2028.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes